Clinical Trial Update: Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours [Phase 1]

View source ↗

Summary

Phase 1 study of the investigational therapy MBS8(1V270) evaluating safety and preliminary efficacy in patients with advanced solid tumors, including metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Solid Tumors
• Uveal Melanoma

Drugs mentioned

• MBS8(1V270)

Snippet

Sponsor: MonTa Biosciences ApS | Conditions: Advanced Solid Tumor, Uveal Melanoma, Metastatic | Phase 1 | Status: RECRUITING